Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (4759)	7/6/1998 3:13:00 PM
From: Intel Trader	Read Replies (2) \| Respond to of 6136

nah. AGPH is OVERSOLD. We held 25ish, AGPH is coming off its low at 25 1/8, having held support with good volume. The last time we've been here was OCT 96. I'd never say that 22 1/2 isn't a possiblity, but I do think it is highly unlikely. Look for a bounce here. it Just called IR. Claudia said that the company sees no reason why the AGPH's share price has gotten this low. Phone: 619-622-3000 Fax: 619-622-3298 Web Site: agouron.com CEO: Peter Johnson CFO: Steven S. Cowell HR: Pat Moses

To: Steve Fancy who wrote (4759)	7/7/1998 9:39:00 AM
From: Ron Kline	Read Replies (2) \| Respond to of 6136

AGPH has seemed to complete its head and shoulder formation yesterday. I had been concerned about this for some time and was able to get out on the right shoulder a months or so ago. Was not sure I was correct on my reading so I didn't post it here. I would be careful averaging down in a weak stock like AGPH, better to buy a leader to offset poor performance from AGPH. AGPH is a good company but this is not a good time to own the stock IMO. Ron